About
Due to lack of a patent I will not release exactly what the product is. The consumer is any individual suffering from chronic hepatitis. There is an estimated 500 million people throughout the world. This treatment is very conceptual, but due the extensive amount of research involving hepatitis I believe its just a matter development. The treatment will theoretically not only maintain the infection but regress the infection to a less developed state allowing the liver to regenerate. The treatment will also require the development of a medical device.